Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation

• Asıl Yazarlar: Rania Moataz El-Dahmy (Yazar), Ibrahim Elsayed (Yazar), Jihan Hussein (Yazar), Mohammad Althubiti (Yazar), Riyad A. Almaimani (Yazar), Mahmoud Zaki El-Readi (Yazar), Marawan A. Elbaset (Yazar), Bassant M. M. Ibrahim (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2023-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Olmesartan medoxomil (OLM) is a first-line antihypertensive drug with low oral bioavailability (28.6%). This study aimed to develop oleogel formulations to decrease OLM side effects and boost its therapeutic efficacy and bioavailability. OLM oleogel formulations were composed of Tween 20, Aerosil 20...